-
First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial
Stibbe, J. A., de Barros, H. A., Linders, D. G. J., Bhairosingh, S. S., Bekers, E. M., van Leeuwen, P. J., Low, P. S., Kularatne, S. A., Vahrmeijer, A. L., Burggraaf, J. & van der Poel, H. G., 1 May 2023, In: The Lancet Oncology. 24, 5, p. 457-467Research output: Contribution to journal › Article › Academic › peer-review
- All publications
